Literature DB >> 10910080

Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus.

P L Paris1, J S Witte, P A Kupelian, H Levin, E A Klein, W J Catalona, G Casey.   

Abstract

Linkage to a prostate cancer susceptibility locus was recently reported on chromosome 16q23. We now report a region exhibiting a high frequency of allelic imbalance (AI) corresponding to this locus in tumors from 51 men diagnosed with prostate cancer using the same linked markers. The highest frequency of AI was found at markers D16S3096 (45%) and D16S516 (53%) that map to chromosome 16q23.2. In addition, 19 of the 51 (37%) prostate tumors showed interstitial AI involving one or both of these markers. This result strongly suggests that a candidate prostate cancer tumor suppressor gene maps between markers D16S3096 and D16S516. We estimate that the distance between these markers is approximately 118 kb using a Stanford radiation hybrid panel. We observed a positive association with family history (P = 0.048) when comparing those men showing interstitial AI at markers D16S3096 and/or D16S516 with those without any imbalance at these two markers. Taken together, these data suggest that we have precisely localized a region of chromosome 16q23.2 that may harbor a prostate cancer tumor suppressor gene implicated in the development of non-familial and possibly familial forms of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910080

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.

Authors:  J Cui; M P Staples; J L Hopper; D R English; M R McCredie; G G Giles
Journal:  Am J Hum Genet       Date:  2001-04-11       Impact factor: 11.025

2.  Deletion and mutation of WWOX exons 6-8 in human non-small cell lung cancer.

Authors:  Yulong Zhou; Yongjian Xu; Zhenxiang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Genome-wide linkage scan for prostate cancer susceptibility from the University of Michigan Prostate Cancer Genetics Project: suggestive evidence for linkage at 16q23.

Authors:  Ethan M Lange; Jennifer L Beebe-Dimmer; Anna M Ray; Kimberly A Zuhlke; Jaclyn Ellis; Yunfei Wang; Sarah Walters; Kathleen A Cooney
Journal:  Prostate       Date:  2009-03-01       Impact factor: 4.104

4.  Genomewide scan for prostate cancer-aggressiveness loci.

Authors:  J S Witte; K A Goddard; D V Conti; R C Elston; J Lin; B K Suarez; K W Broman; J K Burmester; J L Weber; W J Catalona
Journal:  Am J Hum Genet       Date:  2000-05-24       Impact factor: 11.025

5.  Recurrent alterations of the WW domain containing oxidoreductase gene spanning the common fragile site FRA16D in multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Hiroshi Handa; Yoshiko Sasaki; Hikaru Hattori; Lobna Alkebsi; Tetsuhiro Kasamatsu; Takayuki Saitoh; Takeki Mitsui; Akihiko Yokohama; Norifumi Tsukamoto; Morio Matsumoto; Hirokazu Murakami
Journal:  Oncol Lett       Date:  2017-07-26       Impact factor: 2.967

6.  Genetics of prostate cancer.

Authors:  Kai Qi Zhang; Sherry A Salzman; D J Reding; Brian K Suarez; William J Catalona; James K Burmester
Journal:  Clin Med Res       Date:  2003-01

7.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

8.  WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear.

Authors:  C Gourley; A J W Paige; K J Taylor; D Scott; N-J Francis; R Rush; C M Aldaz; J F Smyth; H Gabra
Journal:  Int J Oncol       Date:  2005-06       Impact factor: 5.650

9.  High-resolution analysis of paraffin-embedded and formalin-fixed prostate tumors using comparative genomic hybridization to genomic microarrays.

Authors:  Pamela L Paris; Donna G Albertson; Janneke C Alers; Armann Andaya; Peter Carroll; Jane Fridlyand; Ajay N Jain; Sherwin Kamkar; David Kowbel; Pieter-Jaap Krijtenburg; Daniel Pinkel; Fritz H Schröder; Kees J Vissers; Vivienne J E Watson; Mark F Wildhagen; Colin Collins; Herman Van Dekken
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

Review 10.  Genetic susceptibility to prostate cancer: a review.

Authors:  Bas A J Verhage; Lambertus A L M Kiemeney
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.